Skip to content
Indigenous, Medical Health Aged Care

MSAC support funding pharmacists in First Nations Primary Health Services

Pharmaceutical Society of Australia (PSA) 3 mins read

12 July 2023

The Pharmaceutical Society of Australia (PSA) and the National Aboriginal Community Controlled Health Organisation (NACCHO) have welcomed today’s release of Medical Services Advisory Committee (MSAC) advice supporting funding to embed non-dispensing pharmacists within Aboriginal Health Services.  

 

Australia’s principal medical advisory group’s recommendation is based on a joint submission from PSA, NACCHO and James Cook University (JCU) calling for funding for the Integrating Pharmacists within Aboriginal Community Controlled Health Services to improve Chronic Disease Management (IPAC) project.

 

The IPAC project integrated 26 pharmacists into 18 Aboriginal Community Controlled Health Organisations for 15 months across Queensland, Victoria, and the Northern Territory. Through the project, some Aboriginal Community Controlled Health Services embedded pharmacists directly into their services, while others worked with community pharmacies to deliver pharmacy services.

 

The independent expert advice recognises the significant impact pharmacists can have when integrated into comprehensive primary healthcare teams.

 

MSAC considered that the model was safe and effective compared to usual care. MSAC considered that the estimated costs for providing this integrated, collaborative, culturally appropriate patient-centred care to improve health outcomes for Aboriginal and Torres Strait Islander peoples was good value for money.

 

NACCHO and PSA are looking forward to working with government on rolling-out this important service nationally. PSA and NACCHO also recognise the leadership of JCU on this work that has led to this successful outcome.

 

Quotes attributable to the Chair of NACCHO Donnella Mills

 

"Aboriginal and Torres Strait Islander peoples continue to experience a higher burden of chronic disease due to cardiovascular, diabetes and other health problems than other Australians. 

 

“We are thrilled that that this independent medical advisory group has officially supported funding for integrating pharmacists into ACCHOs’ model of care.

 

Quotes attributable to PSA National President Dr Fei Sim FPS

 

“Through the IPAC project, pharmacists have proven how valuable we are in improving the health outcomes of Aboriginal and Torres Strait Islander peoples’ health. 

 

“One-third of pharmacists involved in the IPAC project were contracted from community pharmacies, highlighting further opportunities for capacity building initiatives within the pharmacy sector to collaboratively deliver better health outcomes for Aboriginal and Torres Strait Islander people.

 

“PSA is proud to have co-designed the Deadly pharmacists: foundation training for pharmacists working within Aboriginal Community-Controlled Health Services, which more than 900 pharmacists have accessed since its launch in late 2022, but we must continue to work together to improve health outcomes for Aboriginal and Torres Strait Islander people.

 

Quotes attributable to the Chair of NACCHO Donnella Mills

 

"Having the support of MSAC confirms when pharmacists are present within our services, both patients and staff at the clinic are better supported to provide safe and effective use of medicine. 

 

“Our member services have been calling for support and funding for non-dispensing pharmacists integrated into ACCHOs for years, this endorsement further validates their requests and demonstrates the impact of team-based community-controlled healthcare.

 

“Now that support for funding for pharmacists integrated into ACCHOs has been provided through the advisory committee, we look forward to working with government on how it can be rolled-out nationally.”

 

Quotes attributable to PSA National President Dr Fei Sim FPS

 

“Both NACCHO and PSA are ready and willing to work with the Federal Government to implement a collaborative model of care which meets the needs of the Aboriginal and Torres Strait Islander people and is consistent with the Federal Government’s commitment to the Priority Reforms of the National Closing the Gap Agreement.”

 

 

Media Contacts:

 

Georgia Clarke (PSA)  M: 0410 505 315     E: [email protected] 

Verity Leach (NACCHO) M: 0438 944 113 E: [email protected]  

More from this category

  • Energy, Medical Health Aged Care
  • 12/03/2026
  • 12:11
Sweltering Cities

The cost of keeping cool is making Australians sick: New report reveals millions forced to ration cooling during record heat

12 March 2026 Sweltering Cities has today released the findings of its 2026 Summer Survey, exposing a national health crisis driven by the rising cost of keeping cool. With data from more than 2,600 respondents across 766 postcodes, the report proves that for many Australians the high cost of staying cool is having serious physical and mental health impacts. The 2025/26 summer saw 68% of all respondents report feeling unwell due to heat. However, the survey reveals that this burden is falling most heavily on those already struggling with the cost of living. For renters and people with disabilities, the…

  • Education Training, Indigenous
  • 12/03/2026
  • 12:05
Charles Darwin University

Yol?u man charts new course for his homelands

AYolÅ‹u man is excited to lure in adventure tourists thanks to his passion to start an eco-tourism venture, with the support of Charles Darwin…

  • Contains:
  • Medical Health Aged Care
  • 12/03/2026
  • 10:01
Monash University

Monash Researchers Awarded up to $22.4 Million AUD to Develop New Medicines for Restoring Lymphatic Pumping

Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop first-in-class medicines designed to reverse poor lymphatic vessel contraction and transport function, backed by an up to $22.4 million AUD Award from the Advanced Research Projects Agency for Health (ARPA-H). The researchers join ARPA-H’s GLIDE (Groundbreaking Lymphatic Interventions and Drug Exploration) program to transform how both primary lymphatic diseases and common chronic diseases are treated by developing innovative therapeutics that alleviate, repair or regenerate a dysfunctional lymphatic vascular system. Professor Arthur Christopoulos, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, said the work…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.